Study shows tagatose may combat antibiotic-resistant C. difficile infections
A new UConn study reveals that tagatose, a plant-based sugar alternative, shows promise in mitigating Clostridioides ...
Frontiers22d
Ocrelizumab-induced colitis—critical review and case series from a Romanian cohort of MS patients
Among these, drug-induced colitis is a rare, but severe side effect ... Infectious screening was performed (stool culture, stool ova and parasite test, C. difficile testing) with negative results for ...
gut.bmj23d
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease
Background Several randomised clinical trials (RCTs) performing faecal microbiota transplantation (FMT) for the management of inflammatory bowel disease (IBD), particularly for ulcerative colitis ...
Healthline26d
Can you cure microscopic colitis or will it return?
Microscopic colitis is a lifelong condition that causes symptoms such as diarrhea and abdominal pain. It is a type of inflammatory bowel disease (IBD). While there is no cure for microscopic ...
Medical News Today28d
Differences and similarities between proctitis and ulcerative colitis
Proctitis affects the rectum, whereas ulcerative colitis can affect the colon, the rectum, or both parts of the intestine. Ulcerative colitis (UC) is a form of inflammatory bowel disease (IBD ...
Medscape1mon
Fidaxomicin: A New Macrocyclic, RNA Polymerase-inhibiting Antibiotic for the Treatment of Clostridium difficile Infections
Mild Clostridium difficile infection (CDI; stool frequency <four-times daily; no signs of severe colitis), clearly induced by the use of antibiotics, may be treated by stopping the inducing ...
Pharmaceutical Technology1mon
EXL-01 by Exeliom Biosciences for Clostridioides difficile Infections (Clostridium difficile Associated Disease): Likelihood of Approval
EXL-01 is under development for the treatment of gastric cancer, hepatocellular cancer, non-small cell lung cancer, Clostridium difficile infection and ulcerative colitis. It is a microbiome based ...
Frontiers4y
Butyrate Mitigates Weanling Piglets From Lipopolysaccharide-Induced Colitis by Regulating Microbiota and Energy Metabolism of the Gut–Liver Axis
Butyrate is known as a primary energy source for colonocytes and functional substances for mitigating pathological features of colitis. However, it is still unclear whether butyrate alleviates colitis ...
Medscape12y
Fidaxomicin: A Novel Macrocyclic Antibiotic for the Treatment of Clostridium difficile Infection
Purpose The pharmacology, clinical efficacy, safety, dosage and administration, and place in therapy of fidaxomicin for the treatment of Clostridium difficile infection (CDI) are reviewed.